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ABSTRACT 
Background 
Occult blood loss from the gastrointestinal tract (GIT), causing iron deficiency often 
with anaemia, can be diagnostically and therapeutically challenging. This is because 
the endoscopic and radiologic tests may be negative due to the slow, chronic and 
intermittent nature of the gastrointestinal bleeding, making timing key in detection 
and localisation of the bleed. These limitations can be approached using two 
different radioactive isotopes. Firstly, we tested the sensitivity of extending Cr-51 
RBC for 21 days relative to 5 days to detect GIT bleeding and its use to optimise 
timing of a Tc-99m RBC study for GIT blood loss localisation. Finally, we tested if the 
information provided by the Tc-99m RBC study aided gastroenterologic intervention 
for anatomical localisation of a lesion. 
Method 
In this retrospective review, after obtaining institutional and ethics committee 
approval, records of patients referred for evaluation of possible GIT blood loss were 
reviewed. In each; daily appearance of radiochromium in stool was measured in the 
whole body counter. In those cases exceeding 50 ml/day, a technetium-99m (Tc-
99m) localization study was performed. These studies were correlated with clinical 
findings. 
Results 
A total of 59 Cr-51 RBC studies were carried out in 36 females and 21 males (n = 
57). In 32 (54%) the radiochromium results were positive with 75% of the bleeding 
incidences occurring after 5 days of stool collection. Of 17 cases in whom Tc-99m 
Stellenbosch University  http://scholar.sun.ac.za
 5 
 
RBC imaging studies were performed, 14 (82%) were positive with specific 
anatomical sites successfully defined in twelve. In all patients with blood loss of >100 
ml/24h, Tc-99m RBC were positive and localised. Ten of the 17 Tc-99m RBC studies 
were further investigated and half diagnosed with small-bowel angiodysplasia. 
Conclusion 
This sequential twin isotope method is practical in revealing otherwise silent 
intestinal haemorrhage. Although it has good patient acceptability and clinical as well 
as diagnostic utility in management, further studies are required to clearly establish a 
cut-off level of blood loss for performing imaging studies and the impact of the 
findings on the overall patient management. 
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OPSOMMING 
Agtergrond 
Die evaluasie van okkulte bloedverlies uit die gastro-intestinale kanaal (GIT), met 
gevolglike ystertekort anemie, kan diagnosties en terapeuties uitdagend wees. 
Dit is omdat endoskopiese en radiologiese ondersoeke negatief mag wees as gevolg 
van die stadige, chroniese en intermitterende aard van die gastro-intestinale 
bloeding, wat die presiese tydstip van opsporing en lokalisering van die bloeding 
krities belangrik maak. Hierdie beperkings kan aangespreek word deur twee 
verskillende radioaktiewe isotope te gebruik. 
Eerstens is die sensitiwiteit van die verlenging van die Cr-51 RBS studie tot 21 dae 
in plaas van 5 dae om die GIT bloeding op te spoor, getoets, asook die gebruik 
daarvan om die optimale tyd vir ‘n Tc-99m RBS studie om die GIT bloedverlies te 
lokaliseer, vas te stel.  
Laastens is getoets of die inligting van die Tc-99m RBS studie wel bygedra het tot 
die gastroenterologiese ingreep om die letsel anatomies te lokaliseer. 
Metode 
Na institusionele en etiese komitee toestemming is inligting van pasiënte wat vir die 
evaluering van ‘n moontlike GI bloedverlies verwys is, in hierdie retrospektiewe 
oorsig nagegaan. Die daaglikse voorkoms van radioaktiewe chroom in 
stoelgangmonsters is in ‘n heelliggaamteller gemeet. In gevalle waar dit 50 ml/dag 
oorskry het, is ‘n tegnesium 99m (Tc 99m) studie gedoen. Hierdie studies is met d ie 
kliniese bevindinge gekorreleer. 
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Resultate 
‘n Totaal van 59 Cr-51 RBS studies is in 36 vroue en 21 mans (n = 57) gedoen. 
Die gemerkte chroomstudies was positief in 32 (54%), met 75% van die bloedings 
wat meer as 5 dae na versameling van die stoelgang plaasgevind het. 
In veertien (82%) van die 17 gevalle waar Tc-99m RBS studies gedoen is, was die 
studies positief. Spesifieke anatomiese gebiede van bloeding kon in 12 hiervan 
suksesvol bevestig word. Tc-99m RBS studies was positief in al die pasiënte met ‘n 
bloedverlies van >100 ml/24h, en kon gelokaliseer word. Tien van die 17 Tc-99m 
RBS studies is verder ondersoek en die helfte daarvan gediagnoseer met dunderm 
angiodisplasie. 
Gevolgtrekking 
Die opeenvolgende twee isotoopmetode om andersins asimptomatiese 
dermbloeding op te spoor, is prakties uitvoerbaar. Alhoewel die studies goed deur 
pasiënte aanvaar is, en ook van kliniese en diagnostiese waarde in die hantering van 
die pasiënte is, is verdere studies nodig om die afsnypunt vir die hoeveelheid 
bloedverlies om beeldingstudies uit te voer, sonder twyfel vas te stel, asook om die 
impak van die bevindings op ‘n groter pasiëntpopulasie vas te stel. 
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INTRODUCTION 
Chronic blood loss, particularly from the GIT, may be difficult to demonstrate yet 
frequently attracts consultation because of otherwise unexplained albeit symptomatic 
iron deficiency anaemia (IDA)1,2. The identification of site of bleeding can be a 
challenge clinically 3. 
It is recommended by the American Gastroenterological Association, the British 
Society of Gastroenterology (BSG) and other reports that faecal occult blood test 
(FOT), upper and lower endoscopy as well as barium studies be routinely used in 
evaluating such patients2,4,5,6. However, it has been shown by Lucas et al that 
investigation of the majority of patients with IDA is suboptimal7. 
In patients with IDA the bleeding is often silent, recurrent, or intermittent8. This 
makes timing of the investigation key in the ultimate objective of detection, 
localization and characterization of the bleeding to aid treatment9. Diagnostic 
imaging often consists of radiologic and endoscopic techniques2,4. Endoscopic 
investigations (gastroscopy and colonoscopy) form the primary investigative modality 
however it has been shown to have low sensitivity in patients with iron deficiency10. 
Radiologic techniques of barium enema, small bowel series, conventional 
enteroclysis and conventional computed tomography have low diagnostic yield4,11,12. 
Computed tomographic (CT) small bowel studies (enteroclysis and enterography), 
CT angiography and conventional angiography give substantial patient radiation 
exposure, are invasive and most importantly do not image for long durations which is 
key in identifying obscure and intermittent bleedings.9. The newer techniques of 
wireless capsule endoscopy and double-balloon enteroscopy show lots of diagnostic 
optimism in small bowel disease. However, in a meta-analysis it was recommended 
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that timing of the study was key in improving the outcome of capsule endoscopy13. 
With double balloon enteroscopy, it is impossible to visualize the whole gut in a 
single study, it is not widely available, is expensive and there are increased chances 
of pancreatitis and bowel perforation14. 
Tc-99m RBC scanning is widely used for detection of gastrointestinal blood loss. It 
allows active blood loss detection at  rates of 0.05 - 0.10 ml/min15,16,17. It is non-
invasive, requires no special patient preparation and can be imaged over a 24 h 
period, increasing the possibility of the detection of obscure and intermittent 
bleeding18. The additional use of SPECT/CT has been shown to increase precision 
of interpretation of scintigraphic findings, increasing diagnostic accuracy of 
conventional scans and correlative diagnoses. However, larger studies are needed 
to categorise patients with GIT bleeding that will benefit from the hybrid 
investigation19,20. 
It is evident that the sensitivity of detection of bleeding site by these investigative 
modalities depends strongly on the occurrence of active blood loss at the time of the 
investigation. To improve diagnostic yield it is crucial to conduct the investigation at 
active bleeding periods. The use of FOT for this role is flawed as it generates a high 
rate of false positive results, it is insensitive and non-specific21, it depends on 
changing factors including fluctuating factors and metabolism of the haemoglobin 
which results in a false negative test22 and gives no indication of the amount of blood 
loss23. Cr-51 RBC is the gold standard for detection and quantification of blood loss 
in stool and earlier studies have established its utility in documenting blood 
loss23,24,25,26. The radiation dose is also very low as very small doses are used for the 
study27. Despite these advantages, Cr-51 RBC’s has not found a significant clinical 
Stellenbosch University  http://scholar.sun.ac.za
 12 
 
role in patient with difficult to diagnose GIT bleeding. The reason for this may in part 
be related to the unpleasant nature of the investigation.  
The study using Cr-51 RBC for detection and quantification of blood loss is usually 
conducted over a 3-5 day period. These studies were not primarily targeted at silent 
intermittent GIT bleeding. The fact that the physical half life of Cr-51 is 28 days and 
only 1% of the Cr-51 elutes from the red cell per day28, allows the detection and 
quantification of bleeding to be extended beyond 5 days (up to 21 days). We are not 
aware of any literature on this innovative method of extending the duration of the  
Cr-51 RBC studies to aid the timing of the Tc-99m RBC imaging studies. 
The aims of our study were to evaluate whether: 
1. Extended Cr-51 RBC measurements increase sensitivity for detecting and 
quantifying GIT bleeding; 
2. Cr-51 RBC measurements can be used to optimise timing of a Tc-99m RBC 
localisation study (the twin isotope method); 
3. The information provided by the Tc-99m RBC study can aid gastroenterologic 
intervention (lesion diagnosis and treatment). 
We report a retrospective analysis evaluating the usefulness of this investigative 
algorithm in our study population. 
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METHODS 
Patients 
The records from all consecutive cases (n=57) referred to the Nuclear Medicine 
Department of Tygerberg Hospital with chronic iron deficiency anaemia for Cr-51 
RBC studies from January 2002 to December 2009 were retrospectively reviewed 
after Institutional Health Research Committee approval. These patients had negative 
initial GIT endoscopies and barium studies. In each case the indication was 
confirmed and the procedure performed according to internationally accepted 
guidelines including compliance with radiation safety. 
Case notes analyses 
Patient case-notes were analysed for demographic information, confirmation of the 
indications, results of previous investigations, and results of the extended Cr-51 RBC 
study and the Tc-99m RBC study results if performed. These data were entered into 
a spreadsheet so that the trend of blood loss, and when imaging studies were 
ordered, could be evaluated. In addition, the diagnoses at the repeat endoscopic 
investigation were also documented.  
Cr-51 RBC labelling and faecal quantitation  
After radiochromation according to the method described by Mollison29, the labelled 
blood was injected and a standard retained. During the period of study all stools 
were collected in 1 liter containers. These were brought to the nuclear medicine 
department on alternate days. Stool samples were counted in a whole body counter 
together with a standard and 5 ml anticoagulated blood samples which were 
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collected on alternate days. The standard is used for quality control purposes to 
monitor the count variations in the whole body counter (which is mostly negligible).  
Blood loss was calculated according to the following formula: 
Blood loss in ml=Total count per minute of stool sample/counts per minute per ml of 
blood30 (background corrected). 
According to O’Neill et al blood loss >3 ml/day was regarded as abnormal31. 
The technique described by Ebaugh FG et al for collection and preparation of stool 
samples and standard consisted of stool collection over a period of 4 days30. We 
modified this technique by collecting stool samples over a longer period up to 21 
days. 
Technetium-99m labelled RBC imaging 
In those individuals losing more than 50 ml blood per day this study was performed 
within 24 h, by labelling erythrocytes in vitro using Tc-99m and an UltraTag® RBC kit. 
Patients were scanned according to the Society of Nuclear Medicine (SNM) 
procedure guideline for gastrointestinal bleeding scintigraphy (version 1.0, approved 
February 1999). In a few cases, imaging studies were also performed when less 
than 50 ml blood loss has been detected based on the decision of the responsible 
nuclear medicine physician at that time. These included three studies (blood loss 45 
ml, 48 ml and 49 ml) in which decision to image was purely based on clinical 
grounds 
In one patient, there was also a clinical suspicion that excessive menstrual blood 
loss could be the cause of iron deficiency. During the study period the menstrual 
Stellenbosch University  http://scholar.sun.ac.za
 15 
 
volume was also determined by collecting and counting the sanitary pads. Actual 
loss was calculated using the same formula as for the stool. 
Clinical follow-up and correlation 
Based on the results of the RBC imaging, independent gastroenterologists 
performed endoscopic procedures to examine the localised site of bleeding and 
interpreted the findings in conjunction with clinical data. 
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RESULTS 
A total of 59 radiochromium studies were carried out in 57 patients, 21 males and 36 
females, age range 1.5 yrs to 81 yrs with a mean age of 50 yrs (Table 1). In one 
patient, three studies were done over a two year period. Menstrual blood loss of 76 
ml was calculated in one patient over a menstrual period of 4 days.  
Table 1: List of patients with the results of the Cr-51 and Tc-99m RBC studies 
Patient 
number 
Age 
(years) Gender 
Radiochromium blood loss 
Technetium-99m 
result 
Result 
Highest volume 
(ml/24h) 
1 67 M negative 1.4 not done 
2 66 M positive 8 not done 
3 72 M positive 59 not done 
4 65 M positive 96.7 negative 
5 72 M positive 20 not done 
6 25 M negative 0.8 not done 
7 69 M positive 756 positive 
8 37 F positive 10.7 not done 
9 75 M negative 1.5 not done 
10 64 M negative 1.4 not done 
11 73 F positive 212 positive 
12 23 F negative 2 not done 
13 3 M negative 3 not done 
14 15/12 F negative 3 not done 
15 36 F positive 504 positive 
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16 60 F positive 88 positive 
17 74 F positive 59 not done 
18 33 F negative 0.6 not done 
19 52 F negative 0.3 not done 
20a 47 M positive 
14 
not done 
20b 47 M positive 48 positive 
20c 47 M positive 83 positive 
21 52 F positive 45 not done 
22 59 F positive 50 positive 
23 81 M positive 145 positive 
24 54 F negative 1.1 not done 
25 70 M positive 49 Negative 
26 7 M Positive 7.4 not done 
27 66 F negative 2.2 not done 
28 47 F positive 118 not done 
29 70 F positive 5.1 not done 
30 47 F positive 6.5 not done 
31 72 F positive 38.4 not done 
32 77 F positive 239 Positive 
33 49 F negative 1 not done 
34 69 F positive 66.7 Negative 
35 16 F negative 1 not done 
36 11 M negative 0.01 not done 
37 34 F negative 1 not done 
38 50 M positive 60 positive 
39 41 M positive 3.6 not done 
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40 68 M positive 84 positive 
41 46 M positive 5.1 not done 
42 25 F negative 1.2 not done 
43 58 F positive 150 positive 
44 15 M negative 0.4 not done 
45 67 M positive 5.3 not done 
46 48 F negative 1 not done 
47 51 F negative 2 not done 
48 19 F negative 1 not done 
49 77 F positive 45 positive 
50 19 F negative 1.6 not done 
51 35 F negative 1 not done 
52 71 F negative 2 not done 
53 48 F negative 2 not done 
54 79 F negative 2 not done 
55 31 F negative 2 not done 
56 34 F negative 2 not done 
57 77 F positive 193 positive 
 
The Cr-51 RBC results were positive in 32 (54%) patients including all the 
examinations in the individual undergoing the 3 studies (table 2). The volume of 
blood loss ranged from 5.1 ml to 756 ml.  
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Table 2: Summary of demographics and results of radionuclide studies 
Study Age (years) Sex Result 
Range Mean F M Positive Negative Total 
Cr-51 RBC 1.5-81 50 36 21 32 (54%) 27 (46%) 59 
Tc-99m RBC 36 -81 65 9 8 14 (80%) 3 (20%) 17 
 
The result of the extended Cr-51 RBC (table 3 and fig 1) shows the majority (75%) of 
the positive Cr-51 RBC occurred after 5 days. 
 
Table 3: Extended Cr-51 RBC results 
Cr-51 RBC 3-50 ml/24h >50 ml/24h 
Day of Positivity ≤5 days >5 days ≤5 days >5 days 
Number 2 14 6 10 
 
When a binomial exact test is used to statistically compare the proportion of positive 
Cr-51 RBC at 5 days (8/59) and at 21 days (32/59), the p value is <0.001 This is very 
significant and demonstrates that extending the Cr-51 RBC to 21 days enhances 
detection of GIT bleed. 
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Fig 1: Shows number of patients in whom bleeding was detected in ≤5 days and  
>5 days after commencement of Cr-51 RBC study.  
 
Three patients with Cr-51 blood loss greater than 50 ml were not imaged. Two had 
initial levels of 59 ml adjudged to be border line and subsequent measurements were 
below 50 ml. One lost 118 ml on one occasion. However, these could not be 
confirmed and the study was then not conducted. 
Tc-99m labeled RBC imaging followed in 17 of the 32 positive radiochromium 
studies. Three of these 17 patients had Cr-51 RBC results of less than 50 ml (45 ml, 
48 ml and 49 ml) and were classified in the 3-50 ml group. The decision to image 
was made on clinical grounds. There were 14 (82%) positive Tc-99m RBC studies 
(table 4), two of which were conducted at less than 50 ml (45 ml and 48ml). 
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Table 4: List of patients’ imaging results and scintigraphic anatomical localisation 
Study 
Code 
Age 
(years) 
Sex Tc-99m  
RBC Result Site of bleeding 
4 65 M negative  negative 
7 69 M positive  hepatic flexure (ascending colon) 
11 73 F positive  midline (small bowel) 
15 36 F positive  midline (small bowel) 
16 60 F positive midline (difficult to localise) 
20b 47 M positive  midline (small bowel) 
20c 47 M positive midline (small bowel) 
22 59 F positive  right iliac fossa 
23 81 M positive  right lumbar (ascending colon) 
25 70 M negative  negative 
32 77 F positive  central (small bowel) 
34 69 F negative  negative 
38 50 M positive  midline (small bowel) 
40 68 M positive  left side of midline (small bowel) 
43 58 F positive  left iliac fossa (small bowel) 
49 77 F positive  difficult to localise 
57 77 F positive  right lower quadrant (caecum, ascending 
colon) 
 
The site of bleeding was localized in 11 of the 12 positive studies in the >50 ml/24h 
group and in the 3-50 ml/24h group 1 was localized (table 5).  
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Table 5: Summary of Cr-51 RBC and Tc-99m RBC results with the number of  
Tc-99m RBC studies that were accurately localised  
Blood loss(ml/24h) <3  (Negative) 3 – 50  >50  
Cr -51 RBC 27 (46%) 16 (27%) 16 (27%) 
Tc-99m RBC Not Performed Performed in 3 Performed in 14 
Tc-99m RBC pos - 2 12 
Tc-99m RBC neg - 1 2 
Bleeding site localised - 1 11 
pos = positive; neg = negative 
Classifying the 17 Tc-99m RBC studies into two groups of <100 ml/24h and >100 
ml/24h led to an important finding. In all studies performed at >100 ml/24h, the  
Tc-99m RBC studies were positive (100%) and localized (100%). However, in the 
<100 ml/24h group, it was positive in 7 (70%) and localized in 5 (50%) of the studies 
(table 6). Using the Fishers exact test for unpaired proportions (5/10 and 7/7) the p 
value is 0.044. This is significant and shows that in our patient population at Cr-51 
RBC blood loss of >100 ml/24h there is a 100% likelihood of Tc-99m RBC positivity 
and localization. 
Table 6 Summary of the seventeen Tc-99m RBC studies performed and classified 
into two groups of <100 ml/24h and > 100 ml/24h 
Blood loss (ml/24h) <100 >100 
Total number of studies 10 7 
Tc-99m RBC study Positive 7 (70%) 7 (100%) 
Bleeding site localized 5 (50%) 7 (100%) 
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Ten of the fourteen positive cases were evaluable while three were lost to follow-up 
and one died before further investigations could be done. In 50% the cause was a 
vascular anomaly. Specifically, in four there were angiodysplasia in the small 
intestine and in one in the gastric antrum. In the remaining five, colorectal carcinoma, 
benign jejunal tumor and hiatal hernia were each diagnosed once with diverticular 
disease occurring twice (Table 7 and figure 2). 
Table 7: Clinical follow up of evaluable patients who had positive Tc-99m RBC 
studies 
Study 
Code 
Age 
(years) 
Sex Tc-99m RBC  
Result 
Diagnosis 
7 69 M Positive lost to follow up 
11 73 F Positive gastric antral (Angiodysplasia) 
15 36 F Positive hiatus hernia 
16 60 F Positive lost to follow up 
20 47 M Positive avm/angiodysplasia of the jejunum 
22 59 F Positive  diverticulosis 
23 81 M Positive died before diagnosis could be made 
32 77 F Positive benign jejunal tumor 
38 50 M Positive colorectal carcinoma 
40 68 M Positive angiodysplasia of the duodenum 
43 58 F Positive ileoceacal angiodysplasia  
49 77 F Positive angiodysplasia 
57 77 F Positive diverticular disease 
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Fig 2: Shows the disease diagnoses after Tc-99m RBC study directed repeat 
endoscopy. Half of the evaluable cases were due to angiodysplasia.
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DISCUSSION 
In men and postmenopausal women, GIT bleeding is considered to be the cause of 
iron deficiency anemia until proven otherwise32. When clinically evident, prompt 
treatment is generally effective. However, in many this may be occult and intermittent 
making it difficult to identify, localize and quantify. 
Blood leaking into the bowel lumen varies 11,12,13,14 but up to 3 ml/day is accepted as 
physiological or normal14. In our series 32 (54%) of those tested exceeded this limit.  
The extended Cr-51 RBC study (>5 days) picked up 75% of the patients with 
detected GIT bleeding. This finding is not strange as GIT bleeding is often 
intermittent. Extending the duration of the investigation resulted in increase in the 
ability of the test to detect the presence of bleeding in the GIT.  
As this extended and two phased approach has not yet been described, we decided 
to empirically use 50 ml blood loss on the radiochromium study as cut off to do 
imaging studies. There were 14 (82%) positive Tc-99m RBC studies, two of which 
were conducted at less than 50 ml (45 ml and 48ml) and we clearly localized the site 
of the bleeding in 12 (86%) of the 14 cases. This high detection rate indicated that 
the chosen level of stool positivity (50 ml) was a realistic value. However, the validity 
of this selection will need further confirmation as we also detected positivity at less 
than 50 ml in 2 of 3 patients. A well structured prospective study that includes all 
positive Cr-51 RBC studies will help confirm the existence of a cut-off blood loss 
level.  
A potential value of quantifying Cr-51 RBC in stool is to schedule imaging 
investigations when there is evidence of bleeding, to aid localization of bleeding sites 
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in the GI tract enabling better definition of the pathologic lesion. We are not aware of 
any reports advocating this method to initiate localization studies and to set a level of 
50 ml as realistic in specifying significant haemorrhage. Our study showed that at 
GIT blood loss of >100 ml/24h, there is a 100% detection rate and site of bleeding 
localization rate. However, the sample size is small and further verification is 
required. 
Tc-99m RBC studies directed repeat endoscopic evaluation of the GIT and aided the 
identification of the cause of bleeding in the majority of our patients. In evaluable 
patients, vascular anomalies accounted for 50% of the active lesions identified, the 
majority of which were located in the duodenum or jejunum. Angiodysplasia can 
occur at any level in bowel and be clinically silent or present as occult blood loss33.  
Incidence increases with advancing age to become common in those over 60 yrs33 
accounting for 30-40% of cases34. The average age of our patients with this proven 
diagnosis was 62.5 yrs. 
Although this pathology is the most fequent34, it does need to be distinguished from 
other causes including colorectal carcinoma as there are major differences in 
management32,35.  
In premenopausal women, menstrual blood loss is the commonest reason for iron 
deficiency34 and the contribution from bowel is variable36. Provided the investigation 
is properly structured a single radiochromium study can reliably separate the two 
causes37. In our patient 76 ml of blood loss was measured over a four day period, 
which is below the 80 ml accepted cut-off level for menorrhagia38.  
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The retrospective nature of this study influenced adequate retrieval of patient clinical 
information. Information concerning the treatment of identified cause of bleeding, and 
whether this resulted in subsequent cessation of the bleeding and normalisation of 
the iron deficiency was unobtainable. In addition, this study is limited as stools were 
not counted every day which could result in missed opportunities for imaging. The 
study is also labour intensive and time consuming for the patients due to frequent 
hospital visits. However, in cases of difficulty in diagnosis and localisation of a GIT 
bleeding site in a patient with iron deficiency it may avoid unnecessary invasive 
procedures.  
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CONCLUSION 
This sequential twin isotope method is a practical way to approach otherwise silent 
bleeding from the bowel. Extension of the Cr-51 RBC study for more than 5 days 
increased GIT bleeding detection rate. Further studies are required to clearly 
establish a cut-off level and the impact of the findings on the overall patient 
management. However, the study is well accepted by patients, can avoid 
unnecessary diagnostic procedures and have clinical as well as diagnostic utility in 
management of chronic iron deficiency anaemia.  
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